250 related articles for article (PubMed ID: 34758330)
1. TIAM1-RAC1 promote small-cell lung cancer cell survival through antagonizing Nur77-induced BCL2 conformational change.
Payapilly A; Guilbert R; Descamps T; White G; Magee P; Zhou C; Kerr A; Simpson KL; Blackhall F; Dive C; Malliri A
Cell Rep; 2021 Nov; 37(6):109979. PubMed ID: 34758330
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
[TBL] [Abstract][Full Text] [Related]
3. Vulnerability of Small-Cell Lung Cancer to Apoptosis Induced by the Combination of BET Bromodomain Proteins and BCL2 Inhibitors.
Lam LT; Lin X; Faivre EJ; Yang Z; Huang X; Wilcox DM; Bellin RJ; Jin S; Tahir SK; Mitten M; Magoc T; Bhathena A; Kati WM; Albert DH; Shen Y; Uziel T
Mol Cancer Ther; 2017 Aug; 16(8):1511-1520. PubMed ID: 28468776
[TBL] [Abstract][Full Text] [Related]
4. Identification of deregulation of apoptosis and cell cycle in neuroendocrine tumors of the lung via NanoString nCounter expression analysis.
Walter RF; Werner R; Ting S; Vollbrecht C; Theegarten D; Christoph DC; Schmid KW; Wohlschlaeger J; Mairinger FD
Oncotarget; 2015 Sep; 6(28):24690-8. PubMed ID: 26008974
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid receptor-mediated apoptosis in small-cell lung cancer requires interaction with BCL2.
Schlossmacher G; Platt E; Davies A; Meredith S; White A
Endocr Relat Cancer; 2013 Dec; 20(6):785-95. PubMed ID: 24036132
[TBL] [Abstract][Full Text] [Related]
6. Balanced Tiam1-rac1 and RhoA drives proliferation and invasion of pancreatic cancer cells.
Guo X; Wang M; Jiang J; Xie C; Peng F; Li X; Tian R; Qin R
Mol Cancer Res; 2013 Mar; 11(3):230-9. PubMed ID: 23322732
[TBL] [Abstract][Full Text] [Related]
7. Tiam1 mediates Rac1 activation and contraction-induced glucose uptake in skeletal muscle cells.
Yue Y; Zhang C; Zhao X; Liu S; Lv X; Zhang S; Yang J; Chen L; Duan H; Zhang Y; Yao Z; Niu W
FASEB J; 2021 Feb; 35(2):e21210. PubMed ID: 33225507
[TBL] [Abstract][Full Text] [Related]
8. Malayoside, a cardenolide glycoside extracted from Antiaris toxicaria Lesch, induces apoptosis in human non-small lung cancer cells via MAPK-Nur77 signaling pathway.
Hu QY; Zhang XK; Wang JN; Chen HX; He LP; Tang JS; Yao XS; Liu J
Biochem Pharmacol; 2021 Aug; 190():114622. PubMed ID: 34043967
[TBL] [Abstract][Full Text] [Related]
9. BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway.
Chen X; Cao X; Tu X; Alitongbieke G; Xia Z; Li X; Chen Z; Yin M; Xu D; Guo S; Li Z; Chen L; Zhang X; Xu D; Gao M; Liu J; Zeng Z; Zhou H; Su Y; Zhang XK
Mol Cancer Ther; 2019 May; 18(5):886-899. PubMed ID: 30926635
[TBL] [Abstract][Full Text] [Related]
10. B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2's apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors.
Banta KL; Wang X; Das P; Winoto A
J Biol Chem; 2018 Mar; 293(13):4724-4734. PubMed ID: 29414782
[TBL] [Abstract][Full Text] [Related]
11. AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer.
Giffin MJ; Cooke K; Lobenhofer EK; Estrada J; Zhan J; Deegen P; Thomas M; Murawsky CM; Werner J; Liu S; Lee F; Homann O; Friedrich M; Pearson JT; Raum T; Yang Y; Caenepeel S; Stevens J; Beltran PJ; Canon J; Coxon A; Bailis JM; Hughes PE
Clin Cancer Res; 2021 Mar; 27(5):1526-1537. PubMed ID: 33203642
[TBL] [Abstract][Full Text] [Related]
12. RBP-J promotes cell growth and metastasis through regulating miR-182-5p-mediated Tiam1/Rac1/p38 MAPK axis in colorectal cancer.
Li F; Zhou YD; Liu J; Cai JD; Liao ZM; Chen GQ
Cell Signal; 2021 Nov; 87():110103. PubMed ID: 34339855
[TBL] [Abstract][Full Text] [Related]
13. MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer.
Cho CY; Lee KT; Chen WC; Wang CY; Chang YS; Huang HL; Hsu HP; Yen MC; Lai MZ; Lai MD
Oncotarget; 2016 Mar; 7(12):14586-604. PubMed ID: 26910843
[TBL] [Abstract][Full Text] [Related]
14. Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch.
Goka ET; Chaturvedi P; Lopez DTM; Lippman ME
Mol Cancer Ther; 2020 Jul; 19(7):1462-1473. PubMed ID: 32371578
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition.
Li D; Tong Q; Lian Y; Chen Z; Zhu Y; Huang W; Wen Y; Wang Q; Liang S; Li M; Zheng J; Liu Z; Liu H; Guo L
Cancer Res Treat; 2021 Oct; 53(4):1042-1056. PubMed ID: 33705625
[TBL] [Abstract][Full Text] [Related]
16. The ratio of Bcl-2/Bim as a predictor of cisplatin response provides a rational combination of ABT-263 with cisplatin or radiation in small cell lung cancer.
Li H; Wang H; Deng K; Han W; Hong B; Lin W
Cancer Biomark; 2019; 24(1):51-59. PubMed ID: 30614795
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C regulates mitochondrial targeting of Nur77 and its family member Nor-1 in thymocytes undergoing apoptosis.
Thompson J; Burger ML; Whang H; Winoto A
Eur J Immunol; 2010 Jul; 40(7):2041-9. PubMed ID: 20411565
[TBL] [Abstract][Full Text] [Related]
18. Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration.
Bourguignon LY; Zhu H; Shao L; Chen YW
J Cell Biol; 2000 Jul; 150(1):177-91. PubMed ID: 10893266
[TBL] [Abstract][Full Text] [Related]
19. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.
Tenjin Y; Kudoh S; Kubota S; Yamada T; Matsuo A; Sato Y; Ichimura T; Kohrogi H; Sashida G; Sakagami T; Ito T
Lab Invest; 2019 Nov; 99(11):1622-1635. PubMed ID: 31231131
[TBL] [Abstract][Full Text] [Related]
20. Identification of expression signatures predictive of sensitivity to the Bcl-2 family member inhibitor ABT-263 in small cell lung carcinoma and leukemia/lymphoma cell lines.
Tahir SK; Wass J; Joseph MK; Devanarayan V; Hessler P; Zhang H; Elmore SW; Kroeger PE; Tse C; Rosenberg SH; Anderson MG
Mol Cancer Ther; 2010 Mar; 9(3):545-57. PubMed ID: 20179162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
